Novelities in the Treatment of Soft-Tissue Sarcomas and GIST

Speaker: George D. Demetri and Peter Reichardt

At ESMO Sarcoma & GIST Conference 2016, G. Demetri and P. Reichardt address different issues important for leading the sarcoma community to more consistent patterns of care. They tackle studying soft-tissue sarcoma subtypes diversity in the light of rare diseases, importance of pathologic diagnosis accompanied with a molecular diagnosis if appropriate, recent drug approvals, resistance to treatment, international collaboration, and patient engagement.

Discussion Points

  • Histology-driven medical therapy
  • Molecularly driven medical therapy
  • Recent highlights in soft-tissue sarcomas treatment
  • How to tackle resistance to therapy
  • Discrepancies in medical treatment of soft-tissue sarcomas and GIST: Heterogeneites in Europe, differences in medical approaches between Europe and US, worldwide perspective on tackling diversities